Similar medications and substitutes for BASILIXIMAB
In short: Simulect (BASILIXIMAB) belongs to the Interleukin-2 Receptor Blocking Antibody class. The medications listed below either share that mechanism of action or have been clinically validated as substitutes when Simulect is unsuitable due to side effects, cost, availability, or contraindications.
No alternatives are listed for Simulect in our database yet. Browse the full medicine index or consult your pharmacist for substitution advice.